As a Principal, Matthew provides strategic counsel to a variety of clients across the life sciences industry. His experience spans a range of therapeutic areas, including oncology, immunology, rare disease, neurology, and infectious disease. He has particular interest working in genetic medicines and other advanced therapies, both in shaping the platform strategy of early-stage companies with innovative technologies and helping to guide larger companies as they determine how to invest in these areas.
Prior to joining ClearView, Matthew received his Ph.D. in Cancer and Stem Cell Biology at the New York University School of Medicine, where his research focused on the role of Wnt signaling and other key signal transduction pathways in tumorigenesis and stem cell maintenance. He received a B.S. in Biological Sciences from Cornell University.
Bill Shew
David Gilman
David McClain
Debbi Amanti Belanger
Debbie Zhuang
Ketan Kapadia
Kevin Richard
Kim Goh
Klaus Bredl
Mike Rizzo
Philip Kenner
Richard Mynahan
Rishi Dalsania
Ryan Tubman
Sam Ulin
Seth Berman
Stephen Chang
Steven Chao
Stuart MacGregor
Jim Caruso
Sidnee Pinho
Kristine Hyde
Charles Mathews
Dave Konciak
Dean Griffiths
Jonathan Betts
Jonathan Hodgson
Mike Roy
Slater Hurst
Alec Marchuk
Alexander Lehrman
Allana Sanborn
Andrew Kang
Austin Hubbert
Beko Binder
Cem Salfati
Jessica Berard
Joanna Lee
Jonny Juliano
Kai-Ming Pu
Kelsey Yardumian
Maneesh Gujrati
Matthew Murphy
Matthew Pfister
Mike Murray
Olivia Piccione
Owen Im
Patrick Kuettner
Peter Goldman
Sarah Stapleton
Soyeon Park
Vini De Nadai
Steve Rubman
Lainey Miller